Determination of the Sun Protection Factor (SPF) of a Cosmetic Daily De-fence Skin Cream

Sunscreening Agents Clinical Trial

Official title: Determination of the Sun Protection Factor of a Cosmetic Daily Defence Skin Cream

Status Completed

Clinical Trial Summary

The purpose of this study is to determine the SPF of the test product according to the International Standards Organization (ISO) 24444:2010 methodology (In vivo determination of the SPF).

Clinical Trial Description

A single-center, randomized, evaluator blind, intra-individual comparison, no treatment and positive controlled clinical study to determine the SPF of Physiogel Daily Defence Protective Day Cream Light as per ISO 24444:2010. The provisional minimal erythemal dose of unprotected skin (MEDu) for each subject will be determined before starting the test phase. Once the provisional MEDu for a subject has been determined, the three test sites will be demarcated. The test product and positive control (P3 reference sunscreen formulation) will be applied to two of the three test sites. The other test site will remain unprotected. All three test sites will be exposed to UV radiation at the expected MED and subsequently evaluated for erythema 16-24 hours after UV exposure. ;

Related Conditions & MeSH terms

• Sunscreening Agents

• NCT number: NCT03136107
• Study type: Interventional
• Source: GlaxoSmithKline
• Status: Completed
• Phase: N/A
• Start date: May 30, 2017
• Completion date: June 30, 2017